| Identification | Back Directory |  [Name]
  11-a-Hydroxy canrenone methyl ester |  [CAS]
  192704-56-6 |  [Synonyms]
  11α-HydroxyMexrenone 11α-Hydroxy Mexrenone 11a-Hydroxy Mexrenone 11alpha-Hydroxymexrenone 11α-Hydroxymexrenone(A2) Eplerenone intermediate A2 11α-HydroxEplerenone Impurity Eplerenone 11α-Hydroxy Analog Eplerenone 11α-Hydroxy Analog 11α-Hydroxy canrenone methyl ester Eplerenone 11-alpha-Hydroxy Analog 11-a-Hydroxy canrenone methyl ester 11-Alpha-Hydroxy canrenone methyl ester TIANFU-CHEM 11-a-Hydroxy canrenone methyl ester 11α,17β-Dihydroxypregn-4-en-3-one 7α,21-dicarboxylic Acid γ-Lactone Methyl Ester 11-ALPHA-HYDROXY-7-ALPHA-(METHOXYCARBONYL)-3-OXOPREGN-4-ENE-21,17-ALPHA-CARBOLACTONE (7α,11α,17α)-11,17-Dihydroxy-3-oxopregn-4-ene-7,21-dicarboxylic Acid γ-Lactone Methyl Ester Pregn-4-ene-7,21-dicarboxylicacid, 11,17-dihydroxy-3-oxo-, g-lactone, methyl ester, (7a,11a,17a)- Pregn-4-ene-7,21-dicarboxylic acid, 11,17-dihydroxy-3-oxo-, γ-lactone, methyl ester, (7α,11α,17α)- methyl (7R,8S,9S,10R,11R,13S,14S,17R)-11-hydroxy-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-carboxylate |  [EINECS(EC#)]
  206-141-6 |  [Molecular Formula]
  C24H32O6 |  [MDL Number]
  MFCD18252911 |  [MOL File]
  192704-56-6.mol |  [Molecular Weight]
  416.507 |  
 | Chemical Properties | Back Directory |  [Boiling point ]
  604.5±55.0 °C(Predicted) |  [density ]
  1.27±0.1 g/cm3(Predicted) |  [storage temp. ]
  Sealed in dry,Room Temperature |  [solubility ]
  Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) |  [form ]
  Solid |  [pka]
  14.40±0.70(Predicted) |  [color ]
  White to Off-White |  [Stability:]
  Hygroscopic |  [InChIKey]
  ZYDNRZOTRVTMRC-ROUXWHDHNA-N |  [SMILES]
  C1[C@]2(C)[C@@]3([H])[C@H](O)C[C@]4(C)[C@]5(CCC(=O)O5)CC[C@@]4([H])[C@]3([H])[C@H](C(OC)=O)CC2=CC(=O)C1 |&1:1,3,5,8,10,18,20,22,r| |  [CAS DataBase Reference]
  192704-56-6 |  
 | Hazard Information | Back Directory |  [Uses]
  11a-Hydroxy Mexrenone is an intermediate used in the chemobiological synthesis of Eplerenone (E588775), a cardiovascular drug. |  [Synthesis]
 
 Under stirring conditions, 5a (5 g, 12 mmol) was dissolved in DMF (40 ml) and heated to 45 °C. Subsequently, AcOH (2.9 ml, 51 mmol) was added to the solution. after 30 min, NaNO2 (2.484 g, 36 mmol) was added slowly in batches. After 1 hour of reaction, DMF (3 ml) solution of AcOH (2.9 ml, 51 mmol) was added dropwise. After 4 hours of reaction, the mixture was cooled to 0°C and quenched with saturated aqueous NaHCO3 solution. Na2SO3 solution (54 ml, 89 mmol) was added. The mixture was warmed to room temperature and stirred overnight. All solvent was removed under vacuum to give a powdered solid. The solid was diluted with acetone, filtered and the filter cake was washed three times with acetone. The organic layer was combined with the filtrate and concentrated to about 100 ml. To the concentrate was added MeI (1.5 ml, 24 mmol) and K2CO3 (5 g, 36 mmol) at 0 °C. The mixture was warmed to room temperature and stirred overnight. The reaction mixture was filtered and the filter cake was washed three times with DCM. The organic layer was combined with the filtrate and all solvents were removed under vacuum. The residue was diluted with DCM, washed sequentially with 10% aqueous HCl, aqueous NaHCO3 and brine, dried with Na2SO4, filtered and the filtrate was concentrated to give the crude product 6. The crude product can be purified by recrystallization from DCM/toluene to give colorless crystals 6 (4 g, 80% yield). The product characterization data were as follows: melting point 230-232 °C; 1H NMR (300 MHz, CDCl3) δ 5.68 (s, 1H), 4.04 (dt, J = 10.23, 9.84, 3.98 Hz, 1H), 3.64 (s, 3H), 2.85-2.71 (m, 2H), 2.68-2.18 (m, 8H), 2.10 -1.57 (m, 9H), 1.49-1.40 (m, 2H), 1.35 (s, 3H), 1.00 (s, 3H); HR-MS (EI) m/z C24H32O6 (M+) calculated value 416.221, measured value 416.225; Elemental analysis of the calculated value (C24H32O6): C 69.21, H 7.74; measured value C 68.32, H 7.72; UV maximum absorption wavelength 244nm.  |  [References]
  [1] Steroids,  2012,  vol. 77,  # 11,  p. 1086 - 1091 |  
  
             | 
            
            
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
             |